Pages that link to "Q52037147"

The following pages link to Linkage analysis of Alzheimer disease with psychosis (Q52037147):

Displaying 30 items.

• Psychosis in Alzheimer's disease (Q26824635) (← links)
• Convergent patterns of association between phenylalanine hydroxylase variants and schizophrenia in four independent samples (Q30435913) (← links)
• Upregulation of CRABP1 in human neuroblastoma cells overproducing the Alzheimer-typical Abeta42 reduces their differentiation potential (Q33393396) (← links)
• Prediction of psychosis onset in Alzheimer disease: the role of depression symptom severity and the HTR2A T102C polymorphism. (Q33635801) (← links)
• Genetics of Psychosis in Alzheimer Disease (Q33666458) (← links)
• Evidence for a novel late-onset Alzheimer disease locus on chromosome 19p13.2. (Q33910032) (← links)
• Accounting for disease model uncertainty in mapping heterogeneous traits--a Bayesian model averaging approach (Q33928102) (← links)
• Genetics of psychosis in Alzheimer's disease: a review (Q34098861) (← links)
• The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE. (Q34123651) (← links)
• Genetics of Alzheimer's disease: a centennial review (Q34656812) (← links)
• Evidence for defective retinoid transport and function in late onset Alzheimer's disease (Q34809021) (← links)
• Psychotic symptoms in Alzheimer disease: evidence for a distinct phenotype (Q35124987) (← links)
• Molecular genetics of late-onset Alzheimer's disease. (Q35821959) (← links)
• Genetic variants associated with susceptibility to psychosis in late-onset Alzheimer's disease families (Q36173669) (← links)
• NMDA Neurotransmission Dysfunction in Behavioral and Psychological Symptoms of Alzheimer's Disease (Q36310524) (← links)
• Synaptic dysfunction and oxidative stress in Alzheimer's disease: emerging mechanisms. (Q36600440) (← links)
• Retinoid receptors, transporters, and metabolizers as therapeutic targets in late onset Alzheimer disease (Q36604044) (← links)
• The relationship of excess cognitive impairment in MCI and early Alzheimer's disease to the subsequent emergence of psychosis (Q37182912) (← links)
• Genetics of psychosis of Alzheimer disease (Q37500251) (← links)
• Genetic risk for schizophrenia and psychosis in Alzheimer disease (Q40219679) (← links)
• Four components describe behavioral symptoms in 1,120 individuals with late-onset Alzheimer's disease (Q40288764) (← links)
• Clinical symptoms in Alzheimer's disease. (Q42438995) (← links)
• Genetic liability to schizophrenia in Oceanic Palau: a search in the affected and maternal generation (Q48201817) (← links)
• Increased familial risk and genomewide significant linkage for Alzheimer's disease with psychosis (Q51915275) (← links)
• Delusion symptoms are associated with ApoE epsilon4 allelic variant at the early stage of Alzheimer's disease with late onset (Q51921138) (← links)
• Robust estimation of critical values for genome scans to detect linkage (Q51989476) (← links)
• Neuregulin-1 polymorphism in late onset Alzheimer's disease families with psychoses. (Q53271430) (← links)
• Linkage to chromosome 14q in Alzheimer's disease (AD) patients without psychotic symptoms. (Q53366990) (← links)
• Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease. (Q53372506) (← links)
• Molecular genetics of Alzheimer’s disease (Q58007043) (← links)